Caricamento...
Type I interferon antagonists in clinical development for lupus
INTRODUCTION: Systemic lupus erythematosus (SLE) is a severe chronic and incurable autoimmune disease. Treatment includes glucocorticoids and small molecule immunosuppressants which typically result in partial responses, and hence there is a great need for new therapies. The type I interferon (IFN)...
Salvato in:
| Pubblicato in: | Expert Opin Investig Drugs |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7924012/ https://ncbi.nlm.nih.gov/pubmed/32700979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2020.1797677 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|